The change affects a program created under the Inflation Reduction Act that provided billions of dollars to Medicare Part D plans. According to The Motley Fool, the demonstration reduced average stand-alone prescription drug plan premiums by $26 in 2025 and by $16 in 2026, easing costs for many older Americans who rely on Medicare coverage.
The announcement comes several months before the next Medicare open enrollment period, giving beneficiaries time to review their coverage and adjust their budgets. For those living primarily on Social Security benefits, even relatively modest increases in monthly healthcare expenses can have an impact on household finances.
Open Enrollment May Become More Important for Medicare Beneficiaries
According to The Motley Fool, the Trump administration announced on July 28 that it is ending the two-year Part D Premium Stabilization Demonstration because it believes the program primarily benefits insurance companies. The policy change will affect seniors enrolled in stand-alone Medicare Part D prescription drug plans that received support through the demonstration.
The article reports that one administration projection estimates affected beneficiaries could face premium increases of up to $20. As a result, seniors may wish to begin incorporating higher prescription drug premiums into their monthly budgets before the changes take effect. Setting aside additional funds, reducing discretionary spending, or using a small portion of savings are among the budgeting strategies discussed in the report.
The Centers for Medicare & Medicaid Services is expected to publish 2027 Medicare premiums in September before the annual Medicare open enrollment period, which runs from Oct. 15 through Dec. 7. During that enrollment window, beneficiaries can compare stand-alone Medicare Part D plans to determine whether lower-cost options are available while still covering their current medications.
The report also notes that beneficiaries may want to consider Medicare Advantage plans that include prescription drug coverage, as the subsidy change primarily affects stand-alone Part D plans rather than Medicare Advantage drug premiums. Medicare’s comparison tools are also highlighted as a resource for evaluating available plans and healthcare costs during open enrollment.
Reviewing Prescription Costs May Help Reduce Overall Expenses
Premiums represent only one part of a beneficiary’s prescription drug expenses. According to The Motley Fool, beneficiaries are encouraged to work with their healthcare providers to review medications and identify potential opportunities to reduce costs where medically appropriate.
The report suggests discussing generic medications or other lower-cost alternatives with physicians when suitable. It also recommends checking whether preferred pharmacies or mail-order services included in a Medicare plan offer lower prescription prices than other pharmacy options. Another recommendation involves periodically reviewing existing prescriptions with a medical provider to determine whether each medication is still necessary. The article emphasizes that any decision to discontinue or change medication should be made with professional medical guidance.
For beneficiaries affected by the end of the subsidy program, these steps may help manage prescription drug spending as Medicare premiums change in 2027. While the demonstration helped reduce monthly premiums during its two-year duration, the upcoming enrollment period provides an opportunity for beneficiaries to evaluate their coverage and consider available options based on their individual prescription needs.
